Detalhe da pesquisa
1.
TGF-ß broadly modifies rather than specifically suppresses reactivated memory CD8 T cells in a dose-dependent manner.
Proc Natl Acad Sci U S A
; 120(48): e2313228120, 2023 Nov 28.
Artigo
Inglês
| MEDLINE | ID: mdl-37988468
2.
A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemia.
Blood
; 130(22): 2410-2419, 2017 11 30.
Artigo
Inglês
| MEDLINE | ID: mdl-29042364
3.
Lysophosphatidic acid receptor 5 inhibits B cell antigen receptor signaling and antibody response.
J Immunol
; 193(1): 85-95, 2014 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24890721
4.
Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy.
J Immunother Cancer
; 10(3)2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35264436
5.
A Fas-4-1BB fusion protein converts a death to a pro-survival signal and enhances T cell therapy.
J Exp Med
; 217(12)2020 12 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32860705
6.
Engineered Adoptive T-cell Therapy Prolongs Survival in a Preclinical Model of Advanced-Stage Ovarian Cancer.
Cancer Immunol Res
; 7(9): 1412-1425, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31337659
7.
Alternative splice forms of CTLA-4 induced by antisense mediated splice-switching influences autoimmune diabetes susceptibility in NOD mice.
Nucleic Acid Ther
; 24(2): 114-26, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24494586
8.
Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.
Cancer Immunol Res
; 1(4): 245-55, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-24455753